Financial documents

File name Publication date Link
Execution of an investment agreement and contribution in kind of a controlling stake by Pléiade Investissement to New Gen Holding, leading to a proposed public tender offer [...] 25-05-2022
Appointment of consulting firm Farthouat Finance as independent expert in connection with New Gen Holding's proposed takeover bid followed, if necessary, by a squeeze-out, for the shares of Generix Group (GENX - FR0010501692) 12-05-2022
Generix Group announces the resumption of its listing as of April 26, 2022 25-04-2022
Generix, its Management, Pléiade Investissement and Montefiore Investment enter into exclusive negotiations with a view to concluding an investment 22-04-2022
Generix Group publishes today its revenues for the 2021/2022 fiscal year 22-04-2022
Acquisition of 100% of Generix Group Portugal 04-04-2022
Q3 2021/2022 revenues: €20.5 M, in line with latest forecasts New SaaS contracts Q3 2021/2022: €1.4 M 27-01-2022
Half-year 2021/2022 Results | EBITDA rate 13,5% 08-12-2021
François Théry joins the Generix Group Executive Committee as Chief Financial Officer 30-11-2021
Ludovic Luzza appointed General Manager of Generix Group North America 30-11-2021
Nicolas Picquerey joins Generix Group's executive committee and takes over the management of its new Consulting entity 23-11-2021
Generix Group announces its strategic plan "BOOST TOGETHER 2025" 16-11-2021
Q2 revenue 2021/2022: strong first half growth, with revenues above 2019-2020 levels 27-10-2021